Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


14.05.2018

1 AIDS
1 BMJ
7 Eur J Gastroenterol Hepatol
4 Gastroenterology
1 Gut
2 Hepatology
1 Int J STD AIDS
2 J Hepatol
2 J Infect Dis
2 J Med Virol
4 J Viral Hepat
1 J Virol
1 Lancet Gastroenterol Hepatol
1 Nature
1 PLoS One
2 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. TARAMASSO L, Montanari L, Di Biagio A
    Hepatitis C virus direct acting antivirals impact on renal function in the first 4 weeks of treatment.
    AIDS. 2018;32:1202-1203.
    PubMed     Text format    


    BMJ

  2. JAKOBSEN JC, Nielsen EE, Koretz RL, Gluud C, et al
    Do direct acting antivirals cure chronic hepatitis C?
    BMJ. 2018;361:k1382.
    PubMed     Text format    


    Eur J Gastroenterol Hepatol

  3. TACHI Y, Hirai T, Kojima Y, Ishizu Y, et al
    Predictive ability of shear wave elastography for pruritus in chronic hepatitis C patients with sustained virological response.
    Eur J Gastroenterol Hepatol. 2018 May 2. doi: 10.1097/MEG.0000000000001159.
    PubMed     Text format     Abstract available

  4. CHEN B, Wang YH, Qian JQ, Wu DB, et al
    Human mesenchymal stem cells for hepatitis B virus-related acute-on-chronic liver failure: a systematic review with meta-analysis.
    Eur J Gastroenterol Hepatol. 2018 May 3. doi: 10.1097/MEG.0000000000001156.
    PubMed     Text format     Abstract available

  5. FOUAD R, Elbaz T, Abdel Alem S, Elsharkawy A, et al
    Evaluation of accuracy of elastography point quantification versus other noninvasive modalities in staging of fibrosis in chronic hepatitis C virus patients.
    Eur J Gastroenterol Hepatol. 2018 May 1. doi: 10.1097/MEG.0000000000001151.
    PubMed     Text format     Abstract available

  6. HASSANY M, Elsharkawy A, Maged A, Mehrez M, et al
    Hepatitis C virus treatment by direct-acting antivirals in successfully treated hepatocellular carcinoma and possible mutual impact.
    Eur J Gastroenterol Hepatol. 2018 May 1. doi: 10.1097/MEG.0000000000001152.
    PubMed     Text format     Abstract available

  7. SPAHR L, Goossens N, Furrer F, Dupuis M, et al
    A return to harmful alcohol consumption impacts on portal hemodynamic changes following alcoholic hepatitis.
    Eur J Gastroenterol Hepatol. 2018 Apr 30. doi: 10.1097/MEG.0000000000001148.
    PubMed     Text format     Abstract available

  8. MENDES LC, Ferreira PA, Miotto N, Zanaga L, et al
    Controlled attenuation parameter for steatosis grading in chronic hepatitis C compared with digital morphometric analysis of liver biopsy: impact of individual elastography measurement quality.
    Eur J Gastroenterol Hepatol. 2018 Apr 30. doi: 10.1097/MEG.0000000000001145.
    PubMed     Text format     Abstract available

  9. AGUILERA A, Trastoy R, Rodriguez-Calvino J, Manso T, et al
    Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain.
    Eur J Gastroenterol Hepatol. 2018 May 8. doi: 10.1097/MEG.0000000000001163.
    PubMed     Text format     Abstract available


    Gastroenterology

  10. MOORMAN AC, Xing J, Nelson NP
    Need for Increasing Hepatitis A Virus Vaccination Among Patients Infected With Hepatitis B Virus and Hepatitis C Virus.
    Gastroenterology. 2018 May 3. pii: S0016-5085(18)34481.
    PubMed     Text format    

  11. LIAW YF, Jeng WJ, Ming-Ling
    Quantitative HBsAg Kinetics in Retreatment Decision for Off-therapy Hepatitis B Flare in HBeAg-Negative Patients.
    Gastroenterology. 2018 May 7. pii: S0016-5085(18)30409.
    PubMed     Text format    

  12. GARDINI AC, Conti F, Brillanti S, Andreone P, et al
    Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals.
    Gastroenterology. 2018 May 7. pii: S0016-5085(18)30419.
    PubMed     Text format    

  13. LOUVET A, Thursz MR, Kim DJ, Labreuche J, et al
    Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data.
    Gastroenterology. 2018 May 5. pii: S0016-5085(18)34495.
    PubMed     Text format     Abstract available


    Gut

  14. WANG K, Lu X, Zhou H, Gao Y, et al
    Deep learning Radiomics of shear wave elastography significantly improved diagnostic performance for assessing liver fibrosis in chronic hepatitis B: a prospective multicentre study.
    Gut. 2018 May 5. pii: gutjnl-2018-316204. doi: 10.1136/gutjnl-2018-316204.
    PubMed     Text format     Abstract available


    Hepatology

  15. ZHANG H, Zhang C, Tang H, Gao S, et al
    CD2-associated Protein Contributes to Hepatitis C Virus Propagation and Steatosis by Disrupting Insulin Signaling.
    Hepatology. 2018 May 5. doi: 10.1002/hep.30073.
    PubMed     Text format     Abstract available

  16. SALAM KA, Wang RY, Grandinetti T, De Giorgi V, et al
    Binding of Free and Immune Complex-Associated Hepatitis C Virus to Erythrocytes Is Mediated by the Complement System.
    Hepatology. 2018 May 9. doi: 10.1002/hep.30087.
    PubMed     Text format     Abstract available


    Int J STD AIDS

  17. BHAGEY A, Foster K, Ralph S, Wardropper A, et al
    High prevalence of anti-hepatitis A IgG in a cohort of UK HIV-negative men who have sex with men: implications for local hepatitis A vaccine policy.
    Int J STD AIDS. 2018 Jan 1:956462418770008. doi: 10.1177/0956462418770008.
    PubMed     Text format     Abstract available


    J Hepatol

  18. GAUCI ML, Baroudjian B, Zeboulon C, Pages C, et al
    Immune-related hepatitis with immunotherapy: Are corticosteroids always needed?
    J Hepatol. 2018 May 7. pii: S0168-8278(18)32025.
    PubMed     Text format    

  19. BERTUCCIO P, Turati F, Carioli G, Rodriguez T, et al
    Global Trends and Predictions in Hepatocellular Carcinoma Mortality.
    J Hepatol. 2017 Mar 20. pii: S0168-8278(17)30145.
    PubMed     Text format     Abstract available


    J Infect Dis

  20. LEE IC, Yang SS, Lee CJ, Su CW, et al
    Incidence and Predictors of HBsAg Loss After Peginterferon Therapy in HBeAg-negative Chronic Hepatitis B: A Multicenter, Long-term Follow-up Study.
    J Infect Dis. 2018 May 7. pii: 4993347. doi: 10.1093.
    PubMed     Text format     Abstract available

  21. VAN BOMMEL F, van Bommel A, Krauel A, Wat C, et al
    Serum HBV RNA as a Predictor of Peginterferon Alfa-2a (40KD) Response in Patients With HBeAg-Positive Chronic Hepatitis B.
    J Infect Dis. 2018 May 8. pii: 4993824. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  22. CELLA E, Riva E, Angeletti S, Fogolari M, et al
    Genotype I Hepatitis A virus introduction in Italy: Bayesian phylogenetic analysis to date different epidemics.
    J Med Virol. 2018 May 8. doi: 10.1002/jmv.25220.
    PubMed     Text format     Abstract available

  23. MARYAM M, Idrees M
    Study of promoter hypomethylation profiles of RAS oncogenes in Hepatocellular Carcinoma derived from Hepatitis C virus genotype 3a in Pakistani population.
    J Med Virol. 2018 May 9. doi: 10.1002/jmv.25221.
    PubMed     Text format     Abstract available


    J Viral Hepat

  24. WANG J, Xia J, Zhang R, Yan X, et al
    A novel index using routinely clinical parameters for predicting significant liver inflammation in chronic hepatitis B.
    J Viral Hepat. 2018 May 9. doi: 10.1111/jvh.12925.
    PubMed     Text format     Abstract available

  25. ZHOU TC, Lai X, Feng MH, Tang Y, et al
    Systematic review and meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis e antigen seroconversion.
    J Viral Hepat. 2018 May 9. doi: 10.1111/jvh.12928.
    PubMed     Text format     Abstract available

  26. CHO YY, Lee JH, Chang Y, Nam JY, et al
    Comparison of overall survival between antiviral-induced viral suppression and inactive phase chronic hepatitis B patients.
    J Viral Hepat. 2018 May 9. doi: 10.1111/jvh.12927.
    PubMed     Text format     Abstract available

  27. CHENG CY, Wu HH, Zou H, Lo YC, et al
    Epidemiological characteristics and associated factors of acute hepatitis A outbreak among HIV-coinfected men who have sex with men in Taiwan, June 2015-December 2016.
    J Viral Hepat. 2018 May 9. doi: 10.1111/jvh.12926.
    PubMed     Text format     Abstract available


    J Virol

  28. NING X, Luckenbaugh L, Liu K, Bruss V, et al
    Common and Distinct Capsid and Surface Protein Requirements for Secretion of Complete and Genome-free Hepatitis B Virions.
    J Virol. 2018 May 9. pii: JVI.00272-18. doi: 10.1128/JVI.00272.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  29. NELSON R
    San Francisco's ambitious plan to eliminate hepatitis C.
    Lancet Gastroenterol Hepatol. 2018;3:378.
    PubMed     Text format    


    Nature

  30. MUHLEMANN B, Jones TC, Damgaard PB, Allentoft ME, et al
    Ancient hepatitis B viruses from the Bronze Age to the Medieval period.
    Nature. 2018 May 9. pii: 10.1038/s41586-018-0097.
    PubMed     Text format     Abstract available


    PLoS One

  31. JIMENEZ-SOUSA MA, Gomez-Moreno AZ, Pineda-Tenor D, Medrano LM, et al
    The IL7RA rs6897932 polymorphism is associated with progression of liver fibrosis in patients with chronic hepatitis C: Repeated measurements design.
    PLoS One. 2018;13:e0197115.
    PubMed     Text format     Abstract available


    Vaccine

  32. BREDBERG A, Boe OW, Bredberg J, Whist JE, et al
    Detection of hepatitis B surface antigen in blood following vaccination.
    Vaccine. 2018 May 4. pii: S0264-410X(18)30600.
    PubMed     Text format    

  33. CHEAH BC, Davies J, Singh GR, Wood N, et al
    Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia.
    Vaccine. 2018 May 4. pii: S0264-410X(18)30122.
    PubMed     Text format     Abstract available


    Virology

  34. SOZZI V, Shen F, Chen J, Colledge D, et al
    In vitro studies identify a low replication phenotype for hepatitis B virus genotype H generally associated with occult HBV and less severe liver disease.
    Virology. 2018;519:190-196.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: